AR117097A1 - PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION - Google Patents

PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION

Info

Publication number
AR117097A1
AR117097A1 ARP190103368A ARP190103368A AR117097A1 AR 117097 A1 AR117097 A1 AR 117097A1 AR P190103368 A ARP190103368 A AR P190103368A AR P190103368 A ARP190103368 A AR P190103368A AR 117097 A1 AR117097 A1 AR 117097A1
Authority
AR
Argentina
Prior art keywords
subcutaneous administration
pharmaceutical formulations
monophosphate
compositions
weight
Prior art date
Application number
ARP190103368A
Other languages
Spanish (es)
Inventor
Sven Stodtmann
Charles S Locke
Weining Z Robieson
Maurizio F Facheris
Nancy Sever
Feroz Jameel
Matthew Rosebraugh
Ehab Moussa
Original Assignee
Abbvie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Inc filed Critical Abbvie Inc
Publication of AR117097A1 publication Critical patent/AR117097A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composiciones de 4’-monofosfato de levodopa y 4’-monofosfato de carbidopa que tienen una relación peso en peso de aproximadamente 20:1 y métodos para tratar el mal de Parkinson y condiciones asociadas mediante la administración subcutánea de dichas composiciones.Compositions of levodopa 4'-monophosphate and carbidopa 4'-monophosphate having a weight-to-weight ratio of about 20: 1 and methods for treating Parkinson's disease and associated conditions by subcutaneous administration of such compositions.

ARP190103368A 2018-11-15 2019-11-15 PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION AR117097A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862767546P 2018-11-15 2018-11-15

Publications (1)

Publication Number Publication Date
AR117097A1 true AR117097A1 (en) 2021-07-07

Family

ID=77369721

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP190103368A AR117097A1 (en) 2018-11-15 2019-11-15 PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION

Country Status (1)

Country Link
AR (1) AR117097A1 (en)

Similar Documents

Publication Publication Date Title
UY37998A (en) ANTIVIRAL AGENTS AGAINST HEPATITIS B
MX2019012676A (en) 2-amino-quinoline derivatives.
CL2017002939A1 (en) Topical pharmaceutical compositions
CL2019001685A1 (en) Amino acid compositions and methods for the treatment of diseases and muscular disorders.
CL2022001743A1 (en) Gamma-Hydroxybutyrate (GHB) Dosage
DOP2018000297A (en) DERIVATIVE OF GLUCAGON, CONJUGATE OF THE SAME, COMPOSITION THAT INCLUDES THE SAME AND THERAPEUTIC USE OF THE SAME
AR110299A1 (en) CONJUGATES UNDERSTANDING A DUAL GLP-1 / GLUCAGON AGONIST, A CONNECTOR AND Hyaluronic Acid
BR112018014027A2 (en) compositions and methods for intravenous administration of 2-bromo-1- (3,3-dinitroazeditin-1-yl) ethanone
CL2019001586A1 (en) Insulin containing pharmaceutical compositions.
CY1122899T1 (en) AQUEOUS FORMULATION INCLUDING PARACETAMOL AND IBUPROPHEN
BR112017000312A2 (en) oral health treatment system for the application of amorphous calcium phosphate, use of one or more basic amino acids, composition, and use of one or more amino acids in an oral health treatment system
PE20210116A1 (en) ORAL ADMINISTRATION OF GLP-1 PEPTIDE ANALOGS
CO2020005919A2 (en) Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases
EA202190308A1 (en) APPLICATION OF DRUGS RILUZOLE FOR TREATMENT OF ALZHEIMER'S DISEASE
CO2019004004A2 (en) Pharmaceutical composition and method for the treatment of non-alcoholic fatty liver disease
AR124078A1 (en) METHOD FOR THE TREATMENT OF PARKINSON'S DISEASE
ECSP21031200A (en) USE OF REBOXETIN FOR THE TREATMENT OF NARCOLEPSY
CO2020004244A2 (en) Methods and compositions for treating chronic lung diseases
CL2020000508A1 (en) Anti-egfr drug-antibody (adc) conjugates and their uses.
AR102778A1 (en) PHARMACEUTICAL COMPOSITION, ITS PREPARATION AND ITS USES
ECSP22040362A (en) 1,2,4OXADIAZOLE DERIVATIVES AS LIVER X RECEPTOR AGONISTS
BR112017015613A2 (en) levodopa and carbidopa intestinal gel and methods of use
UY38473A (en) PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION
CO2023009085A2 (en) Levodopa dosage regimen
AR117097A1 (en) PHARMACEUTICAL FORMULATIONS FOR SUBCUTANEOUS ADMINISTRATION